NPI 1194710418: Open Payments
NPI 1194710418. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$237 in 10 payments from 4 companies in 2025. Trend: 2023 $624 · 2024 $228 · 2025 $237
Food & beverage: $237
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $136 |
| ABBVIE INC. | 2 | $63 |
| PFIZER INC. | 1 | $23 |
| Exact Sciences Corporation | 1 | $15 |
Products named: Ozempic, UBRELVY, Wegovy, ELIQUIS, Cologuard Collection Kit.
